AKUMS DRUGS & PHARMACEUTICALS
Back to Cashflow Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹73 Cr | ₹-108 Cr | ₹125 Cr | ₹236 Cr | ₹-95 Cr |
What is the latest Cash Flow from Financing Activities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹73 Cr |
| Mar2024 | ₹-108 Cr |
| Mar2023 | ₹125 Cr |
| Mar2022 | ₹236 Cr |
| Mar2021 | ₹-95 Cr |
How is Cash Flow from Financing Activities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹73 Cr | Positive | |
| Mar2024 | ₹-108 Cr | Negative | |
| Mar2023 | ₹125 Cr | -47.24 | |
| Mar2022 | ₹236 Cr | Positive | |
| Mar2021 | ₹-95 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹7,709.5 Cr | 3.9% | 12% | -12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 3.9% |
12% |
-12% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses